These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2285642)

  • 1. Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension.
    Malatino LS; Stancanelli B; Greco G; Polizzi G; Assogna G; Zanna C; Tamburino G
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():123-6. PubMed ID: 2285642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
    Tikkanen I; Omvik P; Jensen HA
    J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial.
    Sassano P; Chatellier G; Billaud E; Alhenc-Gelas F; Corvol P; Ménard J
    Am J Med; 1987 Aug; 83(2):227-35. PubMed ID: 3039842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of treatment with ACE and serotonin inhibitors on arterial blood pressure at rest and cycloergometric exercise and on systolic time intervals: comparison of enalapril and ketanserin].
    Cumetti CM; Brina A
    Ann Ital Med Int; 1990; 5(4 Pt 2):503-23. PubMed ID: 2102138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of arterial hypertension in the aged subject with a converting enzyme inhibitor: enalapril].
    Forette F; Handfield-Jones R; Henry-Amar M; Fouchard M; Bouchacourt P; Hervy MP; Henry JF; Mesguisch-Billaud E; Alexandre JM
    Presse Med; 1985 Dec; 14(44):2237-41. PubMed ID: 3003729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study.
    Chalmers JP; Wing LM; West MJ; Bune AJ; Elliott JM; Morris MJ; Cain MD; Graham JR; Southgate DO
    Aust N Z J Med; 1986 Aug; 16(4):475-80. PubMed ID: 3026294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension.
    Gradman AH; Arcuri KE; Goldberg AI; Ikeda LS; Nelson EB; Snavely DB; Sweet CS
    Hypertension; 1995 Jun; 25(6):1345-50. PubMed ID: 7768585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind, cross-over study.
    Fagher B; Katzman P; Hulthén UL; Henningsen NC; Thulin T
    J Intern Med; 1991 Sep; 230(3):219-26. PubMed ID: 1895044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin in the treatment of diabetes-associated hypertension.
    Beretta-Piccoli C
    Drugs; 1988; 36 Suppl 1():35-43. PubMed ID: 3071461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study.
    Omvik P; Thaulow E; Herland OB; Eide I; Midha R; Turner RR
    J Hypertens; 1993 Jan; 11(1):103-13. PubMed ID: 8382234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and hemodynamic effects of antihypertensive treatment with ketanserin.
    Levinson PD; Zimlichman R; Goldstein DS; Brewer HB; Keiser HR
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):245S-248S. PubMed ID: 3415801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ramipril and enalapril in patients with essential hypertension.
    Ruddy MC; Mroczek WJ
    Pharmacotherapy; 1993; 13(3):224-8. PubMed ID: 8321736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistent to enalapril monotherapy.
    Guul SJ; Os I; Jounela AJ
    Am J Hypertens; 1995 Jul; 8(7):727-31. PubMed ID: 7546499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy with ketanserin: metabolic and hemodynamic effects.
    Levinson PD; Zimlichman R; Goldstein DS; Keiser HR
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):384-9. PubMed ID: 2465437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for ACE inhibition in the elderly: treatment of arterial hypertension with enalapril.
    Forette F; Handfield-Jones R; Henry-Amar M; Fouchard M; Bouchacourt P; Hervy MP; Henry JF; Billaud-Mesguish E; Alexandre JM
    Gerontology; 1987; 33 Suppl 1():9-16. PubMed ID: 2831117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.